latest news releases from the newsroom
Emulex Announces Preliminary Third Quarter Results
COSTA MESA, Calif., April 7, 2005 (PRIMEZONE) -- Emulex Corporation (NYSE:ELX), the industry's preeminent source for a broad range of advanced storage networking infrastructure solutions, today announced that it expects to report revenues of approximately $101-102 million for the third fiscal quarter ended March 2005, compared to the range of $91-$93 million projected during the Company's second quarter conference call in January 2005. The Company expects non-GAAP earnings per share for its third fiscal quarter to approximate $0.23-$0.24 per share, compared to the prior projection of $0.18-$0.20. On a GAAP basis, including amortization of intangibles and deferred stock-based compensation, the Company expects to report earnings of approximately $0.18-$0.19 per share, compared to prior guidance of approximately $0.13-$0.15 per share.
Elekta's Nomination Committee Appointed
STOCKHOLM, April 7, 2005 (PRIMEZONE) -- In accordance with the decision at the Annual General Meeting on September 21, 2004, the Chairman of the Board of Elekta AB, Mr Akbar Seddigh, today conducted a meeting with representatives for the company's largest shareholders, forming a nomination committee. The committee will develop a proposal for members of the Board to be submitted to the Annual General Meeting for decision as well as prepare other matters for the AGM.
The Pomerantz Firm Charges Bradley Pharmaceuticals, Inc. with Securities Fraud -- BDY
NEW YORK, April 7, 2005 (PRIMEZONE) -- Pomerantz Haudek Block Grossman & Gross LLP (www.pomerantzlaw.com) has filed a class action lawsuit on April 7, 2005 in the United States District Court for the District of New Jersey, against Bradley Pharmaceuticals, Inc. ("Bradley" or the "Company") (NYSE:BDY) and certain of its officers, on behalf of purchasers of the common stock of Bradley during the period from October 8, 2003 to February 25, 2005, inclusive (the "Class Period").
Natural Harmony Food, Inc.
Natural Harmony Foods to Present at Gulf Coast Venture Forum
FORT LAUDERDALE, Fla., April 7, 2005 (PRIMEZONE) -- Natural Harmony Foods, Inc. (Pink Sheets:NHYF), a producer and marketer of unique, natural protein foods, announced today that its CEO and founder, Sam Dewar, has been selected as the featured presenter at an upcoming meeting of the Gulf Coast Venture Forum on Thursday, April 14, in Boca Raton, Florida.
Parker Waichman Alonso LLP
Parker & Waichman, LLP Applauds FDA Decision to Remove Bextra from Market
NEW YORK, April 7, 2005 (PRIMEZONE) -- Parker & Waichman, LLP commends the FDA's decision to remove Bextra from the U.S. market. In 2004, Parker & Waichman, LLP and Seeger Weiss LLP filed the first Bextra heart attack case in the United States. The case was filed in the Supreme Court of the State of New York, County of New York, against Pfizer Inc. (NYSE:PFE). The suit was on behalf of the estate of a 46 year old man who died of a heart attack while using Bextra. The suit claims that Pfizer has not acted responsibly and has failed to adequately warn consumers about the potential side effects associated with Bextra. Parker & Waichman, LLP and Seeger Weiss LLP intend to file additional suits in the coming weeks on behalf of Bextra users who have suffered heart attacks, strokes and serious skin reactions known as Stevens Johnson Syndrome and Toxic Epidermal Necrolysis. Current and former Bextra patients seeking legal help can visit www.bextralegalhelp.com or www.yourlawyer.com/practice/contact.htm?topic=Bextra.